| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/05/2009 | CA2697949A1 Cancer imaging and treatment |
| 03/05/2009 | CA2697361A1 Alpha-synuclein binding diagnostic agent |
| 03/05/2009 | CA2694084A1 Radiopharmaceutical composition |
| 03/04/2009 | EP2030635A1 Composition for diagnosing amyloid-related disease |
| 03/04/2009 | EP2029616A1 Chemical methods and apparatus |
| 03/04/2009 | EP2029182A2 Stabilisation of radiopharmaceutical precursors |
| 03/04/2009 | EP2029181A2 Methods of making and using rubidium-81-containing compositions |
| 03/04/2009 | EP2029180A2 Compositions and methods for diagnosis of axial pain with or without radiculopathy |
| 03/04/2009 | EP2029179A2 Radiolabelling methods |
| 03/04/2009 | EP2029178A2 Radiopharmaceutical products |
| 03/04/2009 | EP1536844B1 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 03/03/2009 | US7498301 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 03/03/2009 | US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498017 Compositions for delivering nucleic acids to cells |
| 03/03/2009 | CA2304521C Method and apparatus for preparing bi-213 for human therapeutic use |
| 02/26/2009 | WO2009025914A2 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 02/26/2009 | WO2009023961A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | WO2009023955A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | WO2009002669A3 Small peptides specifically bind to colorectal cancers |
| 02/26/2009 | WO2009001046A3 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use |
| 02/26/2009 | WO2008045604A3 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 02/26/2009 | WO2007093451A3 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity |
| 02/26/2009 | US20090055944 Human monoclonal antibodies to be programmed death ligand 1 (pd-l1) |
| 02/26/2009 | US20090053248 Compositions and methods for transepithelial molecular transport |
| 02/26/2009 | US20090053227 Prostate Specific Genes and The Use Thereof in Design of Therapeutics |
| 02/26/2009 | US20090053215 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 02/26/2009 | US20090053137 Chelating Conjugates Having a Substituted Aromatic Moiety and Derivatives Thereof |
| 02/26/2009 | US20090053136 Therapeutic immunoglobulin specific for lymphocyte adhesion protein for killing and/or inhibiting growth of cancer cells |
| 02/26/2009 | DE202006020604U1 Säulensystem zur Herstellung einer Lösung mit hoher spezifischer Aktivität Column system for preparing a solution of high specific activity |
| 02/26/2009 | CA2696684A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | CA2696027A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | CA2689141A1 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 02/25/2009 | EP2027153A2 Dimeric molecular complexes |
| 02/25/2009 | EP2026844A2 Novel imaging agents |
| 02/25/2009 | EP2026840A2 Targeted imaging and/or therapy using the [3+2]-azide-alkyne cycloaddition |
| 02/25/2009 | EP1075277B1 Methods for detecting and inhibiting angiogenesis |
| 02/25/2009 | CN101374555A Methods for measuring the metabolism of neurally derived biomolecules in vivo |
| 02/24/2009 | US7494648 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 02/24/2009 | US7494642 Fatty acid derivatives; tissue-targeted therapy; tomography; cardiovascular disorders; liver disorders; kits |
| 02/19/2009 | WO2007039858A3 Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition |
| 02/19/2009 | US20090048331 Methods and formulations for the delivery of pharmacologically active agents |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090047215 MN/CA IX and Breast Cancer Therapy |
| 02/19/2009 | US20090047214 Novel methylation marker |
| 02/19/2009 | US20090047213 Cytotoxicity mediation of cells evidencing surface expression of CD59 |
| 02/19/2009 | US20090047212 Urothelial differentiation of urothelial carcinoma: a bladder cancer stem cell model |
| 02/19/2009 | US20090047211 Anti-mesothelin antibodies useful for immunological assays |
| 02/19/2009 | US20090047210 Cleavage of VEGF and VEGF receptor by wildtype and mutant MT-SP1 |
| 02/19/2009 | US20090047209 Novel nifedipine compositions |
| 02/19/2009 | DE102007038930A1 Neue chemische Verbindung und deren Verwendung in der Medizin, insbesondere für die Verwendung in der Tumortherapie Novel chemical compound and its use in medicine, particularly for use in tumor therapy |
| 02/19/2009 | CA2696360A1 Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof |
| 02/18/2009 | EP1496946B1 Method for obtaining a 2-18f-fluor-2-deoxy-d-glucose (18f-fdg)-solution |
| 02/18/2009 | EP0969866B2 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 02/18/2009 | CN201195713Y Fluorine-18 nucleophilic reaction apparatus |
| 02/18/2009 | CN101370526A Recombinant monovalent antibodies and methods for production thereof |
| 02/18/2009 | CN101370525A Dual variable domain immunoglobin and uses thereof |
| 02/12/2009 | WO2009020645A2 Matriptase protein and uses thereof |
| 02/12/2009 | WO2009019117A1 Igf-1r binding polypeptides and their use |
| 02/12/2009 | WO2009018761A1 An apatite developing agent and the positron emission temography of the developing agent |
| 02/12/2009 | WO2008036449A9 Chemical antibodies for immunotherapy and imaging |
| 02/12/2009 | US20090041669 Light-Emitting Biomarker |
| 02/12/2009 | US20090041664 5-Pyrrolidinylsulfonyl Isatin Derivatives |
| 02/12/2009 | US20090041663 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 02/12/2009 | US20090041662 Method for Monitoring Patient or Subject Compliance with Medical Prescriptions, and Formulation for Use in the Method |
| 02/12/2009 | US20090041661 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 02/12/2009 | US20090041660 new monoclonal antibodies and binding fragments which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells; antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease |
| 02/12/2009 | US20090041659 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 02/11/2009 | EP2022799A2 Polycistronic expression of antibodies |
| 02/11/2009 | EP2022792A1 Novel compound having affinity to amyloid |
| 02/11/2009 | EP2021036A2 Biomarker generator system |
| 02/11/2009 | CN101365490A Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 02/11/2009 | CN101365460A Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 02/10/2009 | US7488477 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 02/10/2009 | US7488466 Preparation for determining pyrimidine metabolic capacity |
| 02/10/2009 | CA2329776C Antibody against lar phosphatase subunit |
| 02/05/2009 | WO2009018335A2 Targeting brain cells via ophtalmic delivery |
| 02/05/2009 | WO2009018332A1 Single-stranded and double-stranded oligonucleotides comprising a metal-chelating ligand |
| 02/05/2009 | WO2009018175A2 Cyclic azapeptides as integrin markers |
| 02/05/2009 | WO2009018088A2 Imaging of alpha-synuclein |
| 02/05/2009 | WO2008104203A3 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 02/05/2009 | US20090036366 Inhibitors of human plasmin derived from the kunitz domains |
| 02/05/2009 | US20090036365 Inhibitors of human plasmin derived from the kunitz domains |
| 02/05/2009 | US20090035352 Drug Delivery Particle |
| 02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
| 02/05/2009 | US20090035215 Radiofluorination |
| 02/04/2009 | EP2019667A2 Detection and imaging of target tissue |
| 02/04/2009 | CN101360731A Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins |
| 02/04/2009 | CN101360709A Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
| 02/04/2009 | CN100457192C Biotin-derivatives and their conjugates with chelating agents |
| 02/04/2009 | CN100457191C Magnetic nano radioactive medicine and its preparing method |
| 02/04/2009 | CN100457181C Combination methods of inhibiting tumor growth with vascular endothelial growth factor receptor antagonist |
| 02/03/2009 | US7486984 System and method for monochromatic x-ray beam therapy |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485627 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 02/03/2009 | US7485422 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 02/03/2009 | US7485323 Blend of 90-95% of a proteolytic hydrolized gelatin having an average primary amine content of 1.0x10-3 to 1.0x10-2 mu mol of primary amine per mu g of hydrolysate and 5-10% of gelatin; average viscosity of 10 to 15 cP; improved crosslinking and dissolution properties. |
| 02/03/2009 | US7485283 imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging. |
| 02/03/2009 | CA2370409C Colloid for scintigraphy |
| 01/29/2009 | WO2009013358A2 Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions |